Filing Details
- Accession Number:
- 0001790340-25-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-24 09:01:43
- Reporting Period:
- 2025-06-20
- Filing Date:
- 2025-06-24
- Accepted Time:
- 2025-06-24 09:01:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1790340 | Immuneering Corp | IMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870437 | Matthew Brett Hall | 245 Main Street Second Floor Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Transaction Summary
| Purchased: | 13,422 shares | Avg. Price: $2.58 | Total Value: $34,616.17 |
| Number of Shares After Transactions: | 359,318 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2025-06-20 | 7,415 | $2.70 | 353,311 | No | 4 | P | Direct | |
| Class A Common Stock | Acquisiton | 2025-06-23 | 6,007 | $2.43 | 359,318 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.4101 to $2.4299. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Billionaire Hedge Funds
